Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In November 2023, the FDA granted approval for tirzepatide under the brand name Zepbound for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity, as an adjunct to a reduced-calorie diet and increased physical activity
2025 May;27(5):2844-2856
Is microdosing tirzepatide scientifically proven
However, if you are very lean, your healthcare provider might suggest a gentle pinch to ensure the medication does not reach the muscle
PAI-1, Plasminogen activator inhibitor-1
After reconstitution, refrigerate and use within 5-7 days to maintain stability
US$ 29.40
US$ 28.77
US$ 25.28
US$ 20.42
US$ 28.25
US$ 28.60
